.png)
.png)
Director and Senior Statistical Scientist
Berry Consultants
Austin, Texas, United States
Dr. Anna McGlothlin is a Director and Senior Statistical Scientist for Berry Consultants, where she leads statistical design and implementation teams for adaptive and Bayesian clinical trials, with specific expertise in the execution of adaptive platform trials and in early phase clinical trial design. Dr McGlothlin has designed dozens of clinical trials, providing statistical support, including extensive simulations, as well as consulting on interactions with regulators. Dr. McGlothlin has participated in the execution of over 25 adaptive clinical trials, including 5 platform trials, focusing on the interim analyses and interactions with data and safety monitoring boards. A PhD graduate of Baylor University, Dr. McGlothlin has authored or co-authored over a dozen peer-reviewed manuscripts, including 2 first author publications in JAMA that were accompanied by author interview podcasts. She is a highly sought-after instructor for short courses and training, having presented adaptive design and simulation courses to academics, regulators, and industry. Prior to joining Berry Consultants, Dr. McGlothlin was a Senior Research Scientist in early phase oncology at Eli Lilly and Company.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, October 19, 2022
1:30 PM – 3:15 PM US ET
Wednesday, October 19, 2022
1:30 PM – 1:45 PM US ET
Wednesday, October 19, 2022
2:30 PM – 3:15 PM US ET